Head-to-head pharmacological studies were performed, consisting of binding assays (CD20, C1q, FcγRI, FcγRIIa, FcγRIIb, FcγRIIIa-Phe, FcγRIIIa-Val, and FcRn), cell based assays (CDC, ADCC and apoptosis), and in vivo efficacy study (Raji xenograft mouse model) to compare bioactivities of SAIT101 with MabThera® and Rituxan®.

мышиная модель ксенотрансплантата лимфомы человека (лимфома Беркита??) (штамм Раджи)?

Спасибо заранее.